Brief: ExpreS2ion Biotech Q3 EPS SEK -0.44
16/11/2023 07:31
Nov 16 (Reuters) - ExpreS2ion Biotech Q3 net income SEK -21.826 million. * Q3 operating income SEK 1.856 million * Q3 EPS SEK -0.44
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations